HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung cancer risk in the French cohort of uranium miners.

Abstract
The French cohortof uranium miners includes 5098 miners,and 125 lung cancer deaths have been observed. The relationship between radon exposure and risk of lung cancer is estimated using relative risk models, which allow investigation of time dependent modifying factors such as the period of exposure, time since exposure and exposure rate. A linear exposure-response relationship is observed. The main modifier is the period of exposure before or after 1956: the excess relative risk after introduction of ventilation in the French mines is eight times higher than before. The decrease in risk with time since exposure and exposure rate disappears when period of exposure is taken into account. Compared to most of the uranium miner studies, this cohort constitutes a population exposed to low levels and low rates of radon for a long duration. The extension of the French cohort leads to an important increase in its statistical power. Exposure rate effect will be further investigated, in the framework of a European collaborative research project aiming at the synthesis of the effects of radon exposure at low dose and low dose rate.
AuthorsA Rogel, D Laurier, M Tirmarche, B Quesne
JournalJournal of radiological protection : official journal of the Society for Radiological Protection (J Radiol Prot) Vol. 22 Issue 3A Pg. A101-6 (Sep 2002) ISSN: 0952-4746 [Print] England
PMID12400956 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants, Occupational
  • Air Pollutants, Radioactive
  • Uranium
  • Radon
Topics
  • Air Pollutants, Occupational (adverse effects)
  • Air Pollutants, Radioactive (adverse effects)
  • Cohort Studies
  • France
  • Humans
  • Lung Neoplasms (etiology)
  • Mining
  • Neoplasms, Radiation-Induced (etiology)
  • Occupational Diseases (etiology)
  • Radiation Dosage
  • Radon (adverse effects)
  • Risk Factors
  • Uranium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: